A more likely hypothesis explaining increased autotaxin activity in UDCA-treated PSC patients in the present study may be that PSC patients in Norway usually receive UDCA only on specific indication, i.e. flares, pruritus or gallstones, and it may be that patients receiving UDCA had more pruritus or even more serious disease. This evidence concerns the gene ENPP2 and Pruritus.